Juvabis raises €2.0M Seed round
31 December 2019· Zurich, Switzerland· health, drug_discovery, biotech, pharmaceuticals, small_molecule_drugs, b2b
To commence a human trial and subsequently perform a proof-of-concept study in humans, and develop new molecules to treat drug-resistant infections.
About Juvabis
Stage
Seed
Headquarters
Zurich, Switzerland
Founded
2015
Team Size
1–5
Sectors
healthdrug_discoverybiotechpharmaceuticalssmall_molecule_drugsb2b